USPTO 2015–2025 USPTO PatentsView US Corporation

JSR Life Sciences, Llc

USPTO PatentsView assignee record - 31 granted patents across 31 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

12.6

Avg claims per patent

+360%

5-year grant velocity

The verdict

According to USPTO PatentsView, JSR ranks #10,074 of 50,000 tracked US assignees by granted-patent volume, with 31 patents across 31 technology areas.

#10,074
of 50,000 US assignees by volume: Top 15%
by Innovation Score (49.2/100): 12.6
avg claims per patent: +360%
grant velocity, last 5 yrs

Portfolio overview

JSR Life Sciences, Llc has been granted 31 US utility patents between 2018 and 2025, placing JSR Life Sciences, Llc at #10,074 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 31 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.6 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a US Corporation, JSR Life Sciences, Llc is one of the more focused assignees in the PatentsView dataset. By volume, JSR sits between Itoh Denki Co., Ltd. (31 patents, rank #10,068) and Kardion Gmbh (31 patents, rank #10,076) - the closest US assignees by grant volume. The composite Innovation Score of 49.2/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 23 grants, compared with 5 in the 2015–2019 window, a +360% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. JSR Life Sciences, Llc's 12.6 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 31 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Itoh Denki

31
J D Franco &

31
Jiangsu Hengli Ch…

31
JPW Industries

31
Jiangsu Hecheng D…

31
Joyson Safety Sys…

31
K Hartwall OY AB

31
Kardion

31
JSR Life Sciences ◀

31

What this shows JSR holds 31 patents at rank #10,072, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near JSR

By rank, the assignees closest to #10,072 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in JSR's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for JSR, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (49 here).

Sarcos, LC 49 June Life, Llc 49 HFT Solutions, Llc 49 Onward Medical N.v. 49

JSR's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 15% higher than 85% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

JSR Life Sciences, Llc patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	3	9.7%
2019	2	6.5%
2020	6	19.4%
2021	2	6.5%
2022	9	29.0%
2023	2	6.5%
2024	4	12.9%
2025partial year	3	9.7%

Which technologies does JSR Life Sciences, Llc patent most?

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 24

C07K - PEPTIDES 13

C08F - MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS 12

B01J - CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 7

B01D - SEPARATION 6

C08L - COMPOSITIONS OF MACROMOLECULAR COMPOUNDS 5

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 4

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 4

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 3

C09D - COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR 3

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 3

H01F - MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES 2

B82Y - SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES 2

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 2

G02B - OPTICAL ELEMENTS, SYSTEMS OR APPARATUS 2

Top 15 of 31 technology areas

Grant record at a glance

Portfolio Volume 31 grants

CPC subclasses 31

Avg. claims / grant 12.6

Velocity +360%

Historical grant data only; it does not rate legal strength or current strategy.

Where it ranks

Overall rank by patents

#10,074

of 50,000 tracked assignees

Innovation Score

49.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

Where does JSR Life Sciences, Llc rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), JSR Life Sciences, Llc ranks #10,074 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does JSR Life Sciences, Llc hold?

JSR Life Sciences, Llc holds 31 US utility patents granted between 2018 and 2025, spanning 31 technology areas.

What is JSR Life Sciences, Llc's Innovation Score?

JSR Life Sciences, Llc has an Innovation Score of 49.2 out of 100 (top 15% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does JSR Life Sciences, Llc focus on?

JSR Life Sciences, Llc's top technology area is G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES) with 24 patents. Grants appear in 31 CPC subclasses total.

Is JSR Life Sciences, Llc's patent grant rate increasing or decreasing?

JSR Life Sciences, Llc's recent grant velocity is +360% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for JSR Life Sciences, Llc's patents?

JSR Life Sciences, Llc's patents average 12.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the JSR Life Sciences, Llc patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

JSR's 31 grants land it in the top 15% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - JSR ranks #10,074 of 50,000. Top 50 holders
Most of this portfolio concentrates in G01N - see who else leads that technology area. G01N leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.